AstraZeneca shares soar after Pfizer confirms bid talks

Astrazeneca

Related Stories

Shares in pharmaceutical company AstraZeneca rose by more than 14% on Monday, after US giant Pfizer confirmed its interest in a takeover bid.

The firm said it had contacted AstraZeneca over a multi-billion pound bid for the UK-based drug maker.

If successful, the deal would be the biggest ever takeover of a UK firm by a foreign company.

Pfizer said it approached AstraZeneca on Saturday, after an initial offer in January, worth £58.8bn, was rebuffed.

AstraZeneca said the original offer "significantly undervalued" the firm, which employs more than 51,000 staff.

However, AstraZeneca said it was "confident" its strategy would create "significant value" for shareholders on its own.

"The Board remains confident in the ongoing execution of AstraZeneca's strategy as an independent company," it added.

Pfizer's statement this morning is a love letter to AstraZeneca's shareholders.

It talks of "a highly compelling opportunity to realise a significant premium" and offers a "substantial cash payment".

Pfizer also pledges that AstraZeneca shareholders would be able to take up significant rights in any combined company.

Judged by other pharmaceutical deals, any bid of this size would come at a premium of around 30%, presumably on AstraZeneca's undisturbed 17 April share price of £37.81.

With a present market value above £50bn, AstraZeneca would cost Pfizer around £65bn.

Pfizer has the cash, with a multi-billion dollar war chest held off-shore to shield it from American tax laws.

If AstraZeneca does not engage, and it hasn't so far, this bid could turn hostile.

It will be quite a battle.

Pfizer said in a statement that AstraZeneca's refusal to engage meant it was currently "considering its options".

Global player

AstraZeneca manufactures drugs in 16 countries focusing on treatments for diabetes, cancer and asthma as well as antibiotics.

It reported £25.7bn in sales last year, with £3.3bn in pre-tax profit.

In the UK it has eight sites and about 6,700 employees.

Recently it posted a drop in first quarter profits - and laid off thousands of staff in an effort to reduce its costs to compensate for a fall in sales - due to patent losses on blockbuster medicines.

In April, it posted a drop in first quarter profits after its earnings were by hit by patents expiring on some of its older medicines.

'Compelling opportunity'

Pfizer said its initial offer in January was a combination of cash and shares worth £46.61 per AstraZeneca share, worth £58.8bn in total.

At the time, it represented a 30% premium to AstraZeneca's share price, although AstraZeneca's share price has since increased and on Monday morning it jumped nearly 15% to £46.88p.

Pfizer said the deal was "a highly compelling opportunity" for AstraZeneca's shareholders.

It said if the takeover went through, the combined firm would have management in both the US and the UK, but would list its shares on the New York Stock Exchange.

Chart comparing R&D expenditure for UK companies

"We have great respect for AstraZeneca and its proud heritage," said Pfizer chairman and chief executive Ian Read.

Pfizer said it would only make a firm offer if AstraZeneca directors voted unanimously in favour of the deal.

AstraZeneca

Last Updated at 31 Oct 2014, 04:54 ET *Chart shows local time AstraZeneca intraday chart
price change %
4556.00 p +
+56.00
+
+1.24

"The strategic, business and financial rationale for a transaction is compelling," it added.

Hostile move?

Buying AstraZeneca would give Pfizer, whose drugs include Viagra, access to a number of cancer and diabetes drugs.

However, Justin Urquhart Stewart, head of corporate development at Seven Investment Management, told the BBC the price Pfizer is offering was still too low to secure a deal.

"It's too close to what it is priced at in the market," he said.

"They've tried to talk to the management and gain agreement but that's not happened so they are considering now going directly to the shareholders".

Citi analyst Andrew Baum said he believed there was now a 90% chance that Pfizer would acquire AstraZeneca for at least around £49 a share.

Start Quote

AstraZeneca's £7bn of drugs sold every year accounts for a whopping 2.3% of British goods exports.”

End Quote

Linda Yueh, the BBC's chief business correspondent, notes that AstraZeneca is a key UK firm in the area of research and development (R&D) and also in exports.

"AstraZeneca's £7bn of drugs sold every year accounts for a whopping 2.3% of British goods exports," she added.

Pfizer has made other major acquisitions, its most recent being the $68bn (£40.4bn) purchase of Wyeth in 2009.

However, this would mark its biggest foreign acquisition.

It would also be the largest foreign takeover of a British firm, beating some of the more recent deals which include:

  • O2 bought by Spain's Telefonica for £18bn in 2005
  • Cadbury bought by US-based Kraft for £11.5bn in 2010
  • Alliance Boots bought by US investment firm KKR for £11.1bn in 2007
  • BAA bought by Spain's Ferrovial for £10.3bn in 2006
  • Powergen bought by Germany's E.on for £9.6bn in 2002

However, the BBC's business editor, Kamal Ahmed, warned Pfizer's takeover approach could turn into a lengthy battle.

"If AstraZeneca does not engage, and it hasn't so far, this bid could turn hostile," he said.

Reacting to news of the bid, Business Secretary Vince Cable said: "My priority is to ensure that the objectives of this government's life sciences industrial strategy are fulfilled. This means ensuring there are high-skilled jobs and long term investment in research and development in the UK.

"On the potential merger, the CEO of Pfizer has made contact and informed me of his intentions and I have emphasised the importance of these points."

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

More Business stories

RSS

BBC Business Live

  1.  
    08:55: RBS RESULTS

    The chief executive of RBS, Ross McEwan, has told reporters that further branch closures are "inevitable", but he has not set a target number for closures.

     
  2.  
    08:44: RAIL RIP-OFF
    Rail Prices

    The Telegraph has been investigating the price of rail travel, and says it's uncovered a scandal. Passengers using station ticket machines, it claims, are offered widely varying fares by different train companies, and routinely denied the cheapest option. In some cases, a single journey can cost them more than £100 extra.

     
  3.  
    08:26: MARKETS UPDATE

    Predictably, the major European markets have opened with a spring in their step, thriving off the Bank of Japan's announcement earlier.

    • In London, the FTSE 100 is up 0.9% at 6523.07
    • In Frankfurt, the Dax is up 1.6% at 9261.44
    • In Paris, the Cac 40 is up 1.4% at 4198.96
     
  4.  
    08:24: RBS RESULTS

    Ross McEwan says RBS is in talks with regulatory authorities to settle investigations into the foreign exchange rate scandal. Traders at several banks are suspected of colluding to manipulate foreign exchange rates.

     
  5.  
    RBS RESULTS Via Twitter Adam Parsons Business Correspondent

    tweets: "RBS: "Realisticaly we still have some work to do" before paying a dividend"

     
  6.  
    08:15: AIRLINE UPGRADE
    British Airways

    International Airlines Group, the conglomerate made up of British Airways and Spain's Iberia, has reported a 30% rise in profits, and has upgraded its forecasts for the year. The company said it had been successful in controlling costs, helped by new fuel-efficient planes.

     
  7.  
    08:09: RBS

    Trading has just started on the markets in London. RBS shares are up about 2.7% so far.

     
  8.  
    08:02: RBS RESULTS BBC Breakfast
    Breakfast

    Kevin Doran, fund manager at Brown Shipley, says we could see the government sell some of its 80% stake in RBS within the next 12 months. The bank's current value is "very close to fair value", he says, so maybe a sale before the general election?

     
  9.  
    Via Twitter Jamie McGeever, markets correspondent at Reuters

    tweets: "One of the BOJ side-effects - gold falls to a 4-year low of $1,168"

     
  10.  
    07:48: JAPAN STIMULUS

    Bank of Japan Governor Haruhiko Kuroda says Japan is at a "critical moment" in its bid to conquer years of falling prices. "We can say the Japanese economy is now at a critical moment in its process of getting out of deflation," he told reporters in Tokyo. "The (easing) measures this time show the Bank of Japan's unwavering determination to exit deflation."

     
  11.  
    07:43: WWI DEBTS

    We've put a call in to the Treasury, asking them to whom the WWI repayments are being made. Do you know anyone who holds National War Bonds (or 4% Consols, as they were called after a refinancing)? Get in touch by emailing bizlive@bbc.co.uk or tweeting @BBCBusiness.

     
  12.  
    07:40: SONY SLUMPS

    Another important fact from Sony's results. The company is packing up its smartphone business in China.

     
  13.  
    07:35: WWI DEBTS
    South Sea Bubble

    Some of the debt being refinanced by the Treasury dates back to the 18th century, including the "capital stock of the South Sea Company originating in 1711", the collapse of which led to the South Sea Bubble financial crisis of 1720 - depicted by William Hogarth in above print. It's also paying for bonds issued in 1752 and used to finance the Napoleonic and Crimean Wars, the Slavery Abolition Act (1835) and the Irish Distress Loan (1847).

     
  14.  
    RBS RESULTS Via Twitter Douglas Fraser Business and economy editor, Scotland

    tweets: "RBS CEO Ross McEwan: "Still have a long list of conduct + litigation issues + much, much more to do to restore customers' trust"

     
  15.  
    07:27: WWI DEBTS BBC Radio 4

    Simon Jack on Today says paying off the WWI bonds will allow the chancellor to say he's paying off some of the UK's debt, but its pretty insignificant in terms of the overall debt pile. "It's looks good and sounds good," he says.

     
  16.  
    07:23: WWI DEBTS

    The Treasury has announced it is paying off some long-standing debts - dating from WWI, no less. It will redeem £218m of National War Bonds, issued in 1917, with a 5% interest rate. Around £2bn worth of the WWI debt will remain, but the government says it is "looking into the practicalities" of repaying it all.

     
  17.  
    07:17: RBS RESULTS
    RBS

    RBS warns that much more money could be paid out to cover things like the foreign exchange scandal: "Ongoing conduct and regulatory investigations and litigation continue to present challenges" it says, "and are expected to be a material drag on both earnings and capital generation over the coming quarters". It adds that the timing of further settlements or redress "remain uncertain and could be significant".

     
  18.  
    07:09: RBS RESULTS

    RBS has set aside £400m to cover potential fines for manipulating foreign exchange markets, and a further £100m to cover more PPI compensation claims.

     
  19.  
    Via Twitter Joel Hills, business editor at ITV News

    tweets: "Treasury to repay £218m of war debt + look at 'redeeming the entirety of...£2bn of outstanding First World War debts, in due course'."

     
  20.  
    07:05: RBS RESULTS

    RBS also confirms it plans to keep its Irish subsidiary, Ulster Bank. There had been speculation that the company was seeking a buyer for the division.

     
  21.  
    RBS RESULTS 07:02: Breaking News

    RBS reports pre-tax profits of £1.27bn for the three months to the end of September. It has also set aside £780m for litigation costs, including costs related to the foreign exchange rate scandal still being investigated by regulators.

     
  22.  
    06:57: DONUTS BBC Radio 4
    donuts

    Dunkin' Donuts is back in the UK after a 20-year break, Today reports, with five outlets opened this year. The chief executive Nigel Travis tells Simon Jack that its donuts are an "affordable indulgence". He says they offer things like low-fat ice cream and coffees for those who don't want the high-calorie stuff, but most people don't go for it.

     
  23.  
    06:52: SONY SLUMPS
    PS4

    Despite a whopping net loss, there's one bright spot for Sony: Sales of gaming devices are up 83% compared to last year, driven by the popularity of the PS4 console.

     
  24.  
    06:46: SONY SLUMPS
    Sony

    Amid all the jubilancy on the Asian markets, one Japanese company continues to have a rough ride. Sony reported a net loss of 136bn yen (£800m) for for the past quarter, up from a loss of 19.6bn yen (£110m) in the same period last year. The struggling electronic giant says this was largely down to an "impairment of goodwill" in its mobile communications division - that is a decline in the value of intangible assets, such as brand recognition, reputation and intellectual property.

     
  25.  
    06:41: JAPAN BOOSTS STIMULUS BBC World News

    Martin Shulz, a Japan analyst from Fujitsu Research, tells World Business Report that "Abenomics" - the economic policies of prime minister Shinzo Abe - isn't working. "Abenomics is in trouble, the economy isn't improving enough," he says.

     
  26.  
    06:40: RBS BBC Radio 4
    RBS

    Simon Jack's back presenting the news on the Today programme this morning, looking ahead to the RBS results later. Filippo Alloatti from Hermes Investment Management says the bank will probably announce more money set aside to cover PPI claims plus something like £300m-350m to cover fines or expenses relating to the foreign exchange trading scandal.

     
  27.  
    06:24: HALLOWEEN BBC World News
    Rico Hizon

    The Live Page's favourite business reporter Rico Hizon is sporting a black-on-black jacket and shirt combo with an orange tie this morning to celebrate Halloween. "Nothing is spooking the markets", he quipped on Radio 5 Live earlier.

     
  28.  
    06:22: ASIAN MARKETS

    The markets in Japan have now closed, and investors are grinning from ear-to-ear.

    • The Nikkei 225 index surged 4.9% to 16427.06 (highest since November 2007)
    • In Hong Kong, the Hang Seng rose 1.2%, ending at 23990.24

    Stocks in mainland China, India and South East Asia are also up.

     
  29.  
    06:15: JAPAN BOOSTS STIMULUS
    yen

    Here is how the yen reacted to the news from the Bank of Japan - down against the dollar to a six-year low.

     
  30.  
    06:07: JAPAN BOOSTS STIMULUS Radio 5 live

    The Bank of Japan's decision is an attempt to "recharge a fragile economic recovery" and it seems like Prime Minister Shinzo Abe "is getting desperate", our very own Rico Hizon tells Wake Up to Money. He adds that the move "weakened the Japanese Yen against the US Dollar to a level not seen for six years".

     
  31.  
    06:00: JAPAN BOOSTS STIMULUS
    Bank of Japan

    This will give you a sense of how surprising the Bank of Japan's decision to pump more money into the economy was. Bloomberg reports that only three of the 32 economists it had surveyed expected the Bank to ramp up its stimulus programme. In its statement, the BoJ says it was worried about "downward pressure on prices" - or lacklustre inflation, to you and me.

     
  32.  
    06:00: Edwin Lane Business reporter, BBC News

    We're also looking forward to results from Royal Bank of Scotland at 07:00. In May the bank - still 80% owned by us taxpayers - reported profits of £1.6bn, but warned of a tough year ahead. Get in touch with us on bizlivepage@bbc.co.uk or tweet us @BBCBusiness. You email it, we'll publish it. Probably.

     
  33.  
    06:00: Joe Miller Business Reporter

    Good morning. The Bank of Japan has unexpectedly announced a boost to its monetary stimulus programme, in an effort to revive the country's flagging economy. The decision caused Asian markets to soar, with the Nikkei reaching a 7-year high. More on that, and the rest of the morning's business headlines, to follow.

     

Features

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.